Journal article · 2023 · Open access
Fluid biomarkers for the diagnosis of neurodegenerative diseases
Biomarkers in Neuropsychiatry, 8, 100062 · Published 23 March 2023 · DOI 10.1016/j.bionps.2023.100062
In brief
“Fluid biomarkers for the diagnosis of neurodegenerative diseases” is a 2023 journal article by Matthew Luebke and 2 co-authors, published in Biomarkers in Neuropsychiatry. OpenAlex counts 45 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Biomarkers in Neuropsychiatry.
- Citations
- 45
- Most cited in
- 2025 (17)
- Field-weighted impact
- 6.80
- References
- 92
- Authors
- 3
Abstract
In this review, we evaluate the role of fluid biomarkers related to neurodegenerative diseases. Such conditions present diagnostic challenges due to phenotypic heterogeneity, longitudinal evolution, overlap between diagnostic entities, and variability in progression. Biomarkers can potentially provide insight into diagnosis, progression, prognostication, and treatment efficacy. This review covers recent advances in fluid biomarkers including beta-amyloid, tau protein, neurofilament light chain, alpha-synuclein and glial fibrillary protein, and briefly touches upon imaging biomarkers. For each biomarker, we discuss the pathophysiological correlates, clinical uses, accuracy, and limitations.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Luebke, M., Parulekar, M. S., & Thomas, F. P. (2023). Fluid biomarkers for the diagnosis of neurodegenerative diseases. Biomarkers in Neuropsychiatry, 8, 100062. https://doi.org/10.1016/j.bionps.2023.100062
MLA 9
Luebke, Matthew, et al. “Fluid biomarkers for the diagnosis of neurodegenerative diseases.” Biomarkers in Neuropsychiatry, vol. 8, 2023, p. 100062. https://doi.org/10.1016/j.bionps.2023.100062.
Chicago
Luebke, Matthew, Manisha S. Parulekar, and Florian Patrick Thomas. 2023. “Fluid biomarkers for the diagnosis of neurodegenerative diseases.” Biomarkers in Neuropsychiatry 8: 100062. https://doi.org/10.1016/j.bionps.2023.100062.
Harvard
Luebke, M., Parulekar, M. S. and Thomas, F. P. (2023) ‘Fluid biomarkers for the diagnosis of neurodegenerative diseases’, Biomarkers in Neuropsychiatry, 8, p. 100062. doi:10.1016/j.bionps.2023.100062.
IEEE
M. Luebke, M. S. Parulekar, and F. P. Thomas, “Fluid biomarkers for the diagnosis of neurodegenerative diseases,” Biomarkers in Neuropsychiatry, vol. 8, p. 100062, 2023, doi: 10.1016/j.bionps.2023.100062.
BibTeX
@article{luebke2023fluid,
title = {{Fluid biomarkers for the diagnosis of neurodegenerative diseases}},
author = {Luebke, Matthew and Parulekar, Manisha S. and Thomas, Florian Patrick},
journal = {Biomarkers in Neuropsychiatry},
year = {2023},
volume = {8},
pages = {100062},
doi = {10.1016/j.bionps.2023.100062},
url = {https://doi.org/10.1016/j.bionps.2023.100062}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 15 | |
| 2025 | 17 | |
| 2026 | 12 |
Its field-weighted citation impact is 6.80: it has been cited 6.80 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- fluid biomarkers
- neurodegenerative diseases
- amyloid-beta
- tau protein
- neurofilament light chain
- alpha-synuclein
- glial fibrillary acidic protein
- imaging biomarkers
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Luebke, M., Parulekar, M. S., & Thomas, F. P. (2023). Fluid biomarkers for the diagnosis of neurodegenerative diseases. Biomarkers in Neuropsychiatry, 8, 100062. https://doi.org/10.1016/j.bionps.2023.100062
How many times has this paper been cited?
45 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Biomarkers in Neuropsychiatry: sign in and open the full text from this page.
Who wrote this paper?
Matthew Luebke, Manisha S. Parulekar, Florian Patrick Thomas.
What is the DOI of this paper?
10.1016/j.bionps.2023.100062, permanently at https://doi.org/10.1016/j.bionps.2023.100062. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.